Selected research
Industry Research
Nicorette Lozenges Industry Research Report 2026
Market perspective
The global Nicorette Lozenges market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nicorette Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nicorette Lozenges is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nicorette Lozenges is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nicorette Lozenges include Alchem International, Cambrex Corporation, Dr. Reddy's Laboratories, Fertin Pharma, Perrigo Company, Pharmacia, Revolymer, Reynolds American and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nicorette Lozenges market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nicorette Lozenges Market by Company
Alchem International
Cambrex Corporation
Dr. Reddy's Laboratories
Fertin Pharma
Perrigo Company
Pharmacia
Revolymer
Reynolds American
GlaxoSmithKline
Novartis
Johnson & Johnson
Nicorette Lozenges Segment by Type
2 mg/piece Of Gum Dosage
4 mg/piece Of Gum Dosage
Nicorette Lozenges Segment by Application
Individual Smokers
Withdrawal Clinics
Medical Practice
Others
Nicorette Lozenges Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicorette Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicorette Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicorette Lozenges.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicorette Lozenges manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicorette Lozenges by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicorette Lozenges in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 mg/piece Of Gum Dosage
- 4 mg/piece Of Gum Dosage
Applications
- Individual Smokers
- Withdrawal Clinics
- Medical Practice
- Others
Companies covered
- Alchem International
- Cambrex Corporation
- Dr. Reddy's Laboratories
- Fertin Pharma
- Perrigo Company
- Pharmacia
- Revolymer
- Reynolds American
- GlaxoSmithKline
- Novartis
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nicorette Lozenges Market Size (2021-2032)
- 2.2.2 Global Nicorette Lozenges Sales (2021-2032)
- 2.2.3 Global Nicorette Lozenges Market Average Price (2021-2032)
- 2.3 Nicorette Lozenges by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2 mg/piece Of Gum Dosage
- 2.3.3 4 mg/piece Of Gum Dosage
- 2.4 Nicorette Lozenges by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Individual Smokers
- 2.4.3 Withdrawal Clinics
- 2.4.4 Medical Practice
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nicorette Lozenges Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nicorette Lozenges Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Nicorette Lozenges Revenue of Manufacturers (2021-2026)
- 3.4 Global Nicorette Lozenges Average Price by Manufacturers (2021-2026)
- 3.5 Global Nicorette Lozenges Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nicorette Lozenges, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nicorette Lozenges, Product Type & Application
- 3.8 Global Manufacturers of Nicorette Lozenges, Established Date
- 3.9 Global Nicorette Lozenges Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alchem International
- 4.1.1 Alchem International Company Information
- 4.1.2 Alchem International Business Overview
- 4.1.3 Alchem International Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alchem International Nicorette Lozenges Product Portfolio
- 4.1.5 Alchem International Recent Developments
- 4.2 Cambrex Corporation
- 4.2.1 Cambrex Corporation Company Information
- 4.2.2 Cambrex Corporation Business Overview
- 4.2.3 Cambrex Corporation Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cambrex Corporation Nicorette Lozenges Product Portfolio
- 4.2.5 Cambrex Corporation Recent Developments
- 4.3 Dr. Reddy's Laboratories
- 4.3.1 Dr. Reddy's Laboratories Company Information
- 4.3.2 Dr. Reddy's Laboratories Business Overview
- 4.3.3 Dr. Reddy's Laboratories Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy's Laboratories Nicorette Lozenges Product Portfolio
- 4.3.5 Dr. Reddy's Laboratories Recent Developments
- 4.4 Fertin Pharma
- 4.4.1 Fertin Pharma Company Information
- 4.4.2 Fertin Pharma Business Overview
- 4.4.3 Fertin Pharma Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fertin Pharma Nicorette Lozenges Product Portfolio
- 4.4.5 Fertin Pharma Recent Developments
- 4.5 Perrigo Company
- 4.5.1 Perrigo Company Company Information
- 4.5.2 Perrigo Company Business Overview
- 4.5.3 Perrigo Company Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Company Nicorette Lozenges Product Portfolio
- 4.5.5 Perrigo Company Recent Developments
- 4.6 Pharmacia
- 4.6.1 Pharmacia Company Information
- 4.6.2 Pharmacia Business Overview
- 4.6.3 Pharmacia Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pharmacia Nicorette Lozenges Product Portfolio
- 4.6.5 Pharmacia Recent Developments
- 4.7 Revolymer
- 4.7.1 Revolymer Company Information
- 4.7.2 Revolymer Business Overview
- 4.7.3 Revolymer Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Revolymer Nicorette Lozenges Product Portfolio
- 4.7.5 Revolymer Recent Developments
- 4.8 Reynolds American
- 4.8.1 Reynolds American Company Information
- 4.8.2 Reynolds American Business Overview
- 4.8.3 Reynolds American Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Reynolds American Nicorette Lozenges Product Portfolio
- 4.8.5 Reynolds American Recent Developments
- 4.9 GlaxoSmithKline
- 4.9.1 GlaxoSmithKline Company Information
- 4.9.2 GlaxoSmithKline Business Overview
- 4.9.3 GlaxoSmithKline Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GlaxoSmithKline Nicorette Lozenges Product Portfolio
- 4.9.5 GlaxoSmithKline Recent Developments
- 4.10 Novartis
- 4.10.1 Novartis Company Information
- 4.10.2 Novartis Business Overview
- 4.10.3 Novartis Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis Nicorette Lozenges Product Portfolio
- 4.10.5 Novartis Recent Developments
- 4.11 Johnson & Johnson
- 4.11.1 Johnson & Johnson Company Information
- 4.11.2 Johnson & Johnson Business Overview
- 4.11.3 Johnson & Johnson Nicorette Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Johnson & Johnson Nicorette Lozenges Product Portfolio
- 4.11.5 Johnson & Johnson Recent Developments
5 Global Nicorette Lozenges Market Scenario by Region
- 5.1 Global Nicorette Lozenges Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nicorette Lozenges Sales by Region: 2021-2032
- 5.2.1 Global Nicorette Lozenges Sales by Region: 2021-2026
- 5.2.2 Global Nicorette Lozenges Sales by Region: 2027-2032
- 5.3 Global Nicorette Lozenges Revenue by Region: 2021-2032
- 5.3.1 Global Nicorette Lozenges Revenue by Region: 2021-2026
- 5.3.2 Global Nicorette Lozenges Revenue by Region: 2027-2032
- 5.4 North America Nicorette Lozenges Market Facts & Figures by Country
- 5.4.1 North America Nicorette Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nicorette Lozenges Sales by Country (2021-2032)
- 5.4.3 North America Nicorette Lozenges Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Nicorette Lozenges Market Facts & Figures by Country
- 5.5.1 Europe Nicorette Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nicorette Lozenges Sales by Country (2021-2032)
- 5.5.3 Europe Nicorette Lozenges Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Nicorette Lozenges Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nicorette Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nicorette Lozenges Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nicorette Lozenges Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nicorette Lozenges Market Facts & Figures by Country
- 5.7.1 South America Nicorette Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nicorette Lozenges Sales by Country (2021-2032)
- 5.7.3 South America Nicorette Lozenges Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Nicorette Lozenges Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nicorette Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nicorette Lozenges Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nicorette Lozenges Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Nicorette Lozenges Sales by Type (2021-2032)
- 6.1.1 Global Nicorette Lozenges Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Nicorette Lozenges Sales Market Share by Type (2021-2032)
- 6.2 Global Nicorette Lozenges Revenue by Type (2021-2032)
- 6.2.1 Global Nicorette Lozenges Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nicorette Lozenges Revenue Market Share by Type (2021-2032)
- 6.3 Global Nicorette Lozenges Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nicorette Lozenges Sales by Application (2021-2032)
- 7.1.1 Global Nicorette Lozenges Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Nicorette Lozenges Sales Market Share by Application (2021-2032)
- 7.2 Global Nicorette Lozenges Revenue by Application (2021-2032)
- 7.2.1 Global Nicorette Lozenges Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nicorette Lozenges Revenue Market Share by Application (2021-2032)
- 7.3 Global Nicorette Lozenges Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nicorette Lozenges Value Chain Analysis
- 8.1.1 Nicorette Lozenges Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nicorette Lozenges Production Mode & Process
- 8.2 Nicorette Lozenges Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nicorette Lozenges Distributors
- 8.2.3 Nicorette Lozenges Customers
9 Global Nicorette Lozenges Analyzing Market Dynamics
- 9.1 Nicorette Lozenges Industry Trends
- 9.2 Nicorette Lozenges Industry Drivers
- 9.3 Nicorette Lozenges Industry Opportunities and Challenges
- 9.4 Nicorette Lozenges Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst